# Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

> **NCT04341727** · PHASE3 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DRUG:** Hydroxychloroquine Sulfate
- **DRUG:** Azithromycin
- **DRUG:** Chloroquine Sulfate

## Key facts

- **NCT ID:** NCT04341727
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-04
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** DSMB recommended study suspension slow accrual
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341727, "Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04341727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*